ACADIA PHARMACEUTICALS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.15 USD | -0.58% |
|
+0.35% | -45.35% |
| Apr. 30 | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
| Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Other Biotechnology & Medical Research | -0.81% | +0.35% | -45.35% | -20.60% | -34.57% | 2.85B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACAD Stock
- Charts ACADIA Pharmaceuticals Inc.
- Comparison Chart